Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Increasing access to smoking cessation treatment among Latino smokers using case management.

Cartujano-Barrera F, Perales J, Arana E, Cox LS, Yeh HW, Ellerbeck EF, Richter KP, Cupertino AP.

J Smok Cessat. 2019 Sep;14(3):168-175. doi: 10.1017/jsc.2019.1. Epub 2019 Mar 11. No abstract available.

PMID:
31673297
2.

"Every day I think about your messages": assessing text messaging engagement among Latino smokers in a mobile cessation program.

Cartujano-Barrera F, Arana-Chicas E, Ramírez-Mantilla M, Perales J, Cox LS, Ellerbeck EF, Catley D, Cupertino AP.

Patient Prefer Adherence. 2019 Jul 22;13:1213-1219. doi: 10.2147/PPA.S209547. eCollection 2019.

3.

Impact of Adding Telephone-Based Care Coordination to Standard Telephone-Based Smoking Cessation Counseling Post-hospital Discharge: a Randomized Controlled Trial.

Ellerbeck EF, Cox LS, Hui SA, Keighley J, Hutcheson TD, Fitzgerald SA, Cupertino AP, Greiner KA, Rigotti NA, Miller NH, Rabius V, Richter KP.

J Gen Intern Med. 2019 Dec;34(12):2804-2811. doi: 10.1007/s11606-019-05220-2. Epub 2019 Jul 31.

PMID:
31367875
4.

Black Light Smokers: How Nicotine Intake and Carcinogen Exposure Differ Across Various Biobehavioral Factors.

St Helen G, Benowitz NL, Ahluwalia JS, Tyndale RF, Addo N, Gregorich SE, Pérez-Stable EJ, Cox LS.

J Natl Med Assoc. 2019 May 10. pii: S0027-9684(19)30017-3. doi: 10.1016/j.jnma.2019.04.004. [Epub ahead of print]

PMID:
31084916
5.

The Challenge of Managing Atopic Dermatitis in the United States.

Feldman SR, Cox LS, Strowd LC, Gerber RA, Faulkner S, Sierka D, Smith TW, Cappelleri JC, Levenberg ME.

Am Health Drug Benefits. 2019 Apr;12(2):83-93. Review.

6.

Urine Metabolites for Estimating Daily Intake of Nicotine from Cigarette Smoking.

Benowitz NL, Helen GS, Nardone N, Cox LS, Jacob P.

Nicotine Tob Res. 2019 Mar 10. pii: ntz034. doi: 10.1093/ntr/ntz034. [Epub ahead of print]

PMID:
30852610
7.
8.

Optimisation of a screening platform for determining IL-6 inflammatory signalling in the senescence-associated secretory phenotype (SASP).

Rolt A, Nair A, Cox LS.

Biogerontology. 2019 Jun;20(3):359-371. doi: 10.1007/s10522-019-09796-4. Epub 2019 Feb 11. Erratum in: Biogerontology. 2019 Mar 6;:.

9.

Publisher Correction: c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4+ T cells.

Gabryšová L, Alvarez-Martinez M, Luisier R, Cox LS, Sodenkamp J, Hosking C, Pérez-Mazliah D, Whicher C, Kannan Y, Potempa K, Wu X, Bhaw L, Wende H, Sieweke MH, Elgar G, Wilson M, Briscoe J, Metzis V, Langhorne J, Luscombe NM, O'Garra A.

Nat Immunol. 2019 Mar;20(3):374. doi: 10.1038/s41590-019-0331-3.

PMID:
30733606
10.

Generation of a novel model of primary human cell senescence through Tenovin-6 mediated inhibition of sirtuins.

Walters HE, Cox LS.

Biogerontology. 2019 Jun;20(3):303-319. doi: 10.1007/s10522-018-09792-0. Epub 2019 Jan 21.

11.

mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases.

Walters HE, Cox LS.

Int J Mol Sci. 2018 Aug 8;19(8). pii: E2325. doi: 10.3390/ijms19082325. Review.

12.

A randomized clinical trial of counseling and nicotine replacement therapy for treatment of African American non-daily smokers: Design, accrual, and baseline characteristics.

Nollen NL, Cox LS, Mayo MS, Ellerbeck EF, Madhusudhana S, Ahluwalia JS.

Contemp Clin Trials. 2018 Jul;70:72-82. doi: 10.1016/j.cct.2018.05.011. Epub 2018 May 19.

13.

c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4+ T cells.

Gabryšová L, Alvarez-Martinez M, Luisier R, Cox LS, Sodenkamp J, Hosking C, Pérez-Mazliah D, Whicher C, Kannan Y, Potempa K, Wu X, Bhaw L, Wende H, Sieweke MH, Elgar G, Wilson M, Briscoe J, Metzis V, Langhorne J, Luscombe NM, O'Garra A.

Nat Immunol. 2018 May;19(5):497-507. doi: 10.1038/s41590-018-0083-5. Epub 2018 Apr 16. Erratum in: Nat Immunol. 2019 Mar;20(3):374.

14.

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, Azar A, Baroody FM, Bachert C, Canonica GW, Chacko T, Cingi C, Ciprandi G, Corey J, Cox LS, Creticos PS, Custovic A, Damask C, DeConde A, DelGaudio JM, Ebert CS, Eloy JA, Flanagan CE, Fokkens WJ, Franzese C, Gosepath J, Halderman A, Hamilton RG, Hoffman HJ, Hohlfeld JM, Houser SM, Hwang PH, Incorvaia C, Jarvis D, Khalid AN, Kilpeläinen M, Kingdom TT, Krouse H, Larenas-Linnemann D, Laury AM, Lee SE, Levy JM, Luong AU, Marple BF, McCoul ED, McMains KC, Melén E, Mims JW, Moscato G, Mullol J, Nelson HS, Patadia M, Pawankar R, Pfaar O, Platt MP, Reisacher W, Rondón C, Rudmik L, Ryan M, Sastre J, Schlosser RJ, Settipane RA, Sharma HP, Sheikh A, Smith TL, Tantilipikorn P, Tversky JR, Veling MC, Wang Y, Westman M, Wickman M, Zacharek M.

Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352. doi: 10.1002/alr.22073.

15.

Small molecule modulation of splicing factor expression is associated with rescue from cellular senescence.

Latorre E, Birar VC, Sheerin AN, Jeynes JCC, Hooper A, Dawe HR, Melzer D, Cox LS, Faragher RGA, Ostler EL, Harries LW.

BMC Cell Biol. 2017 Oct 17;18(1):31. doi: 10.1186/s12860-017-0147-7.

16.

Intent to quit, quit attempts, and perceived health risk reduction among African American, Latino, and White nondaily and daily smokers in the United States.

Scheuermann TS, Nollen NL, Luo X, Cox LS, Ahluwalia JS.

Ethn Health. 2019 Nov;24(8):855-873. doi: 10.1080/13557858.2017.1390549. Epub 2017 Oct 16.

PMID:
29035089
17.

Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.

Chenoweth MJ, Ware JJ, Zhu AZX, Cole CB, Cox LS, Nollen N, Ahluwalia JS, Benowitz NL, Schnoll RA, Hawk LW Jr, Cinciripini PM, George TP, Lerman C, Knight J, Tyndale RF; PGRN-PNAT Research Group.

Addiction. 2018 Mar;113(3):509-523. doi: 10.1111/add.14032. Epub 2017 Nov 2.

18.

Tobacco toxicant exposure in cigarette smokers who use or do not use other tobacco products.

Nollen NL, Mayo MS, Clark L, Cox LS, Khariwala SS, Pulvers K, Benowitz NL, Ahluwalia JS.

Drug Alcohol Depend. 2017 Oct 1;179:330-336. doi: 10.1016/j.drugalcdep.2017.07.021. Epub 2017 Aug 16.

19.

Immunotherapy and systemic reactions.

Tankersley MS, Cox LS.

Ann Allergy Asthma Immunol. 2017 Aug;119(2):195. doi: 10.1016/j.anai.2017.04.019. No abstract available.

PMID:
28801021
20.

Safety Review of 5-Grass Pollen Tablet from Pooled Data of Clinical Trials.

Casale TB, Cox LS, Wahn U, Golden DBK, Bons B, Didier A.

J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1717-1727.e1. doi: 10.1016/j.jaip.2017.04.020. Epub 2017 Jul 19.

PMID:
28734858
21.

Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles.

Nelson HS, Calderon MA, Bernstein DI, Casale TB, Durham SR, Andersen JS, Esch R, Cox LS, Nolte H.

Curr Allergy Asthma Rep. 2017 Mar;17(3):18. doi: 10.1007/s11882-017-0687-0. Review.

PMID:
28293909
22.

Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?

Cox LS.

JAMA. 2017 Feb 14;317(6):591-593. doi: 10.1001/jama.2017.0128. No abstract available. Erratum in: JAMA. 2017 Mar 21;317(11):1179.

PMID:
28196239
23.

The role of cellular senescence in ageing of the placenta.

Cox LS, Redman C.

Placenta. 2017 Apr;52:139-145. doi: 10.1016/j.placenta.2017.01.116. Epub 2017 Jan 16. Review.

PMID:
28131318
24.

Is the Benefit From Prescribing Epinephrine Autoinjectors for Sublingual Immunotherapy Worth the Cost? Lessons Learned From Clinical Trials.

Portnoy J, Cox LS.

J Allergy Clin Immunol Pract. 2017 Jan - Feb;5(1):90-91. doi: 10.1016/j.jaip.2016.11.008. No abstract available.

PMID:
28065345
25.

Sublingual Immunotherapy: Historical Perspective and Practical Guidance.

Cox LS.

J Allergy Clin Immunol Pract. 2017 Jan - Feb;5(1):63-65. doi: 10.1016/j.jaip.2016.11.016. No abstract available.

PMID:
28065343
26.

World Allergy Organization Systemic Allergic Reaction Grading System: Is a Modification Needed?

Cox LS, Sanchez-Borges M, Lockey RF.

J Allergy Clin Immunol Pract. 2017 Jan - Feb;5(1):58-62.e5. doi: 10.1016/j.jaip.2016.11.009. Review.

PMID:
28065342
27.

Homeless patients' perceptions about using cell phones to manage medications and attend appointments.

Moczygemba LR, Cox LS, Marks SA, Robinson MA, Goode JR, Jafari N.

Int J Pharm Pract. 2017 Jun;25(3):220-230. doi: 10.1111/ijpp.12321. Epub 2016 Nov 29.

PMID:
27896909
28.

Current Evidence on Safety and Practical Considerations for Administration of Sublingual Allergen Immunotherapy (SLIT) in the United States.

Epstein TG, Calabria C, Cox LS, Dreborg S.

J Allergy Clin Immunol Pract. 2017 Jan - Feb;5(1):34-40.e2. doi: 10.1016/j.jaip.2016.09.017. Epub 2016 Nov 1. Review.

PMID:
27815065
29.

Animal and human models to understand ageing.

Lees H, Walters H, Cox LS.

Maturitas. 2016 Nov;93:18-27. doi: 10.1016/j.maturitas.2016.06.008. Epub 2016 Jun 9. Review.

PMID:
27372369
30.

Impact of Telephone-Based Care Coordination on Use of Cessation Medications Posthospital Discharge: A Randomized Controlled Trial.

Tague C, Richter KP, Cox LS, Keighley J, Hutcheson T, Fitzgerald SA, Ellerbeck EF.

Nicotine Tob Res. 2017 Mar 1;19(3):299-306. doi: 10.1093/ntr/ntw138.

PMID:
27194545
31.

Methodological aspects of a meta-analysis of grass pollen allergen sublingual immunotherapy tablets.

Cox LS, Didier A, Demoly P, Wahn U, Pradalier A, Frew AJ, Devillier P.

J Allergy Clin Immunol. 2016 Jul;138(1):314-315.e4. doi: 10.1016/j.jaci.2016.01.039. Epub 2016 Apr 12. No abstract available.

PMID:
27084407
32.

Reversal of phenotypes of cellular senescence by pan-mTOR inhibition.

Walters HE, Deneka-Hannemann S, Cox LS.

Aging (Albany NY). 2016 Feb;8(2):231-44.

33.

A clinical trial to examine disparities in quitting between African-American and White adult smokers: Design, accrual, and baseline characteristics.

Nollen NL, Cox LS, Yu Q, Ellerbeck EF, Scheuermann TS, Benowitz NL, Tyndale RF, Mayo MS, Ahluwalia JS.

Contemp Clin Trials. 2016 Mar;47:12-21. doi: 10.1016/j.cct.2015.12.001. Epub 2015 Dec 5.

34.

Allergen-specific Immunotherapy--Turning the Tables on the Immune System.

Nowak-Węgrzyn AH, Cox LS.

Immunol Allergy Clin North Am. 2016 Feb;36(1):xv-xxi. doi: 10.1016/j.iac.2015.09.001. No abstract available.

PMID:
26617238
35.

Examining Smoking Dependence Motives among African American Light Smokers.

Bronars CA, Faseru B, Krebill R, Mayo MS, Snow TM, Okuyemi KS, Ahluwalia JS, Cox LS.

J Smok Cessat. 2015 Dec 1;10(2):154-161. Epub 2014 Mar 26.

36.

Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2.

Alimbetov D, Davis T, Brook AJ, Cox LS, Faragher RG, Nurgozhin T, Zhumadilov Z, Kipling D.

Biogerontology. 2016 Apr;17(2):305-15. doi: 10.1007/s10522-015-9610-z. Epub 2015 Sep 23.

37.

PCNA tightens its hold on the nucleus.

Cox LS.

Cell Cycle. 2015;14(17):2727-8. doi: 10.1080/15384101.2015.1064699. Epub 2015 Jul 15. No abstract available.

38.

Metadata Correction: Comparative and Cost Effectiveness of Telemedicine Versus Telephone Counseling for Smoking Cessation.

Richter KP, Shireman TI, Ellerbeck EF, Cupertino AP, Catley D, Cox LS, Preacher KJ, Spaulding R, Mussulman LM, Nazir N, Hunt JJ, Lambart L.

J Med Internet Res. 2015 Jun 15;17(6):e124. doi: 10.2196/jmir.4642. No abstract available.

39.

Comparative and cost effectiveness of telemedicine versus telephone counseling for smoking cessation.

Richter KP, Shireman TI, Ellerbeck EF, Cupertino AP, Catley D, Cox LS, Preacher KJ, Spaulding R, Mussulman LM, Nazir N, Hunt JJ, Lambart L.

J Med Internet Res. 2015 May 8;17(5):e113. doi: 10.2196/jmir.3975. Erratum in: J Med Internet Res. 2015;17(6):e124. Catley, Delwyn [Added].

40.

Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males.

Zhu AZ, Cox LS, Ahluwalia JS, Renner CC, Hatsukami DK, Benowitz NL, Tyndale RF.

Pharmacogenet Genomics. 2015 May;25(5):263-9. doi: 10.1097/FPC.0000000000000135.

41.

Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report.

Papadopoulos NG, Bernstein JA, Demoly P, Dykewicz M, Fokkens W, Hellings PW, Peters AT, Rondon C, Togias A, Cox LS.

Allergy. 2015 May;70(5):474-94. doi: 10.1111/all.12573. Epub 2015 Feb 19.

PMID:
25620381
42.

Smoking dependence across the levels of cigarette smoking in a multiethnic sample.

Scheuermann TS, Nollen NL, Cox LS, Reitzel LR, Berg CJ, Guo H, Resnicow K, Ahluwalia JS.

Addict Behav. 2015 Apr;43:1-6. doi: 10.1016/j.addbeh.2014.11.017. Epub 2014 Nov 23.

43.

Winning and losing: differences in reward and punishment sensitivity between smokers and nonsmokers.

Martin LE, Cox LS, Brooks WM, Savage CR.

Brain Behav. 2014;4(6):915-24. doi: 10.1002/brb3.285. Epub 2014 Sep 19.

44.

Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.

Didier A, Wahn U, Horak F, Cox LS.

Expert Rev Clin Immunol. 2014 Oct;10(10):1309-24. doi: 10.1586/1744666X.2014.957677. Epub 2014 Sep 10. Review.

PMID:
25205329
45.

Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes.

Zhu AZ, Zhou Q, Cox LS, Ahluwalia JS, Benowitz NL, Tyndale RF.

Drug Metab Dispos. 2014 Nov;42(11):1971-7. doi: 10.1124/dmd.114.060285. Epub 2014 Sep 3.

46.

Comparison of native light daily smokers and light daily smokers who were former heavy smokers.

Fish LJ, Pollak KI, Scheuermann TS, Cox LS, Mathur C, Ahluwalia JS.

Nicotine Tob Res. 2015 May;17(5):546-51. doi: 10.1093/ntr/ntu169. Epub 2014 Sep 1.

PMID:
25180075
47.

Evidence-based evaluation for allergies to avoid inappropriate testing, diagnosis, and treatment.

Huston DP, Cox LS.

JAMA Intern Med. 2014 Aug;174(8):1223-4. doi: 10.1001/jamainternmed.2014.1413. No abstract available.

PMID:
24911343
48.

Design and participant characteristics of a randomized-controlled trial of telemedicine for smoking cessation among rural smokers.

Mussulman L, Ellerbeck EF, Cupertino AP, Preacher KJ, Spaulding R, Catley D, Cox LS, Lambart L, Hunt JJ, Nazir N, Shireman T, Richter KP.

Contemp Clin Trials. 2014 Jul;38(2):173-81. doi: 10.1016/j.cct.2014.04.008. Epub 2014 Apr 24.

49.

Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.

Zhu AZ, Zhou Q, Cox LS, David SP, Ahluwalia JS, Benowitz NL, Tyndale RF.

Clin Pharmacol Ther. 2014 Aug;96(2):256-65. doi: 10.1038/clpt.2014.88. Epub 2014 Apr 14.

50.

Allergy immunotherapy adherence and delivery route: location does not matter.

Cox LS, Hankin C, Lockey R.

J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):156-60. doi: 10.1016/j.jaip.2014.01.010. No abstract available.

PMID:
24607042

Supplemental Content

Support Center